T Cell Receptors and Immune Therapy Using the Same
Copyright © Targeted News Service 2024
2024-03-26
ALEXANDRIA, Virginia, March 26 -- IMMATICS BIOTECHNOLOGY GMBH, Tuebingen, Germany has been assigned a patent (No. US 11939376 B2, initially filed Aug. 21, 2020) developed by four inventors Leonie Alten, Tuebingen, Germany; Dominik Maurer, Moessingen, Germany; Steffen Walter, Houston, Texas; and Sebastian Bunk, Tuebingen, Germany, for "T cell receptors and immune therapy using the same." . . .